HIGHLIGHTS
- who: Roberto Piergentili and collaborators from the Institute of Molecular Biology and Pathology, Italian National Research Council (CNR-IBPM), Rome, Italy University of Rome, Viale del Policlinico, , Rome, Italy have published the research: Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health, in the Journal: (JOURNAL) of 19/08/2022
- what: This study showed 13 of 34 that MALAT1, via the downregulation of miR-376a, accelerates osteosarcoma via the Wnt/β-catenin pathway , which is a conserved signaling axis participating in diverse physiological processes such as proliferation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.